Search Results - "Medina, Jesús R."
-
1
Discovery of 7‑Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro‑1H‑indol-5-yl)‑7H‑pyrrolo[2,3‑d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
Published in Journal of medicinal chemistry (23-08-2012)“…Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous…”
Get full text
Journal Article -
2
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development
Published in ACS medicinal chemistry letters (10-10-2013)“…We recently reported the discovery of GSK2606414 (1), a selective first in class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK),…”
Get full text
Journal Article -
3
Selective 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitors: dissecting the function and pharmacology of PDK1
Published in Journal of medicinal chemistry (11-04-2013)“…3-Phosphoinositide-dependent protein kinase 1 (PDK1) is a protein target that has generated considerable interest in both academia and the pharmaceutical…”
Get full text
Journal Article -
4
Cell-Based Drug Discovery: Identification and Optimization of Small Molecules that Reduce c‑MYC Protein Levels in Cells
Published in Journal of medicinal chemistry (11-11-2021)“…Elevated expression of the c-MYC oncogene is one of the most common abnormalities in human cancers. Unfortunately, efforts to identify pharmacological…”
Get full text
Journal Article -
5
Selective 3‑Phosphoinositide-Dependent Kinase 1 (PDK1) Inhibitors: Dissecting the Function and Pharmacology of PDK1: Miniperspective
Published in Journal of medicinal chemistry (11-04-2013)“…3-Phosphoinositide-dependent protein kinase 1 (PDK1) is a protein target that has generated considerable interest in both academia and the pharmaceutical…”
Get full text
Journal Article -
6
Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
Published in Journal of medicinal chemistry (24-03-2011)“…Phosphoinositide-dependent protein kinase-1(PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As…”
Get full text
Journal Article -
7
High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells
Published in SLAS discovery (01-02-2021)“…While c-MYC is well established as a proto-oncogene, its structure and function as a transcription factor have made c-MYC a difficult therapeutic target. To…”
Get more information
Journal Article -
8
9-Borabicyclo[3.3.2]decanes and the Asymmetric Hydroboration of 1,1-Disubstituted Alkenes
Published in Journal of the American Chemical Society (23-07-2008)“…The syntheses of the optically pure asymmetric hydroborating agents 1 (a, R = Ph; b, R = TMS) in both enantiomeric forms are reported. These reagents are…”
Get full text
Journal Article -
9
Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery
Published in ACS medicinal chemistry letters (11-11-2010)“…Fragment screening of phosphoinositide-dependent kinase-1 (PDK1) in a biochemical kinase assay afforded hits that were characterized and prioritized based on…”
Get full text
Journal Article -
10
Acylprolinamides: A new class of peptide deformylase inhibitors with in vivo antibacterial activity
Published in Bioorganic & medicinal chemistry letters (15-06-2012)“…A new class of PDF inhibitor with potent, broad spectrum antibacterial activity is described. Optimization of blood stability and potency provided compounds…”
Get full text
Journal Article -
11
Design and synthesis of aminopyridine containing biaryls reducing c-MYC protein levels in cells
Published in Bioorganic & medicinal chemistry letters (15-08-2023)“…[Display omitted] The c-MYC oncogene transcription factor has been implicated in cell cycle regulation controlling cell growth and proliferation. It is tightly…”
Get full text
Journal Article -
12
Discovery of a new series of Aurora inhibitors through truncation of GSK1070916
Published in Bioorganic & medicinal chemistry letters (15-04-2010)“…The SAR results from this investigation will be presented with an emphasis on the impact structural changes have on the cellular phenotype. Novel Aurora…”
Get full text
Journal Article -
13
Benzyl 2-Cyano-3,3-Dimethyl-1-pyrrolidinecarboxylate, a Versatile Intermediate for the Synthesis of 3,3-Dimethylproline Derivatives
Published in Journal of organic chemistry (16-05-2008)“…The synthesis of racemic nitrile (±)-9 was accomplished in four steps and 58% overall yield from the known pyrrolidinone 5. Nitrile (±)-9 was resolved via…”
Get full text
Journal Article -
14
New Δ5,9 Fatty Acids in the Phospholipids of the Sea Anemone Stoichactis helianthus
Published in Journal of natural products (Washington, D.C.) (01-12-1994)Get full text
Journal Article -
15
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1 H -indol-5-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
Published in Journal of medicinal chemistry (23-08-2012)Get full text
Journal Article -
16
New Direct 11B NMR-Based Analysis of Organoboranes through Their Potassium Borohydrides
Published in Journal of organic chemistry (13-06-2003)“…Representative organoborane mixtures were quantitatively converted to their borohydrides through their reaction with activated KH (KH*), permitting their…”
Get full text
Journal Article -
17
Abstract 2919: Discovery of small-molecule compounds targeting c-MYC using a novel cell-based screen
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Elevated expression of the c-MYC oncogene (either due to gene amplification, translocation, abnormality in upstream signaling pathways and/or protein…”
Get full text
Journal Article -
18
Abstract LB-42: PDK1 knockdown selectively inhibits growth of cancer cells harboring activating mutations involved in MAPK signaling
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway…”
Get full text
Journal Article -
19
A mild and general method for the synthesis of 2-substituted-5-hydroxypyrimidines
Published in Tetrahedron letters (09-10-2006)“…5-Bromopyrimidines are converted to 5-hydroxypyrimidines using a mild synthetic procedure. The method is general and can be applied to compounds containing…”
Get full text
Journal Article -
20
Abstract LB-116: GSK2334470: A potent and highly selective inhibitor of PDK1
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway…”
Get full text
Journal Article